chol-fus1
Gene therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2003 (NCT00059605)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor suppressor candidate 2Supplementation
supplementation - fus1
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- chol-fus1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01455389 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2014 | Genprex, Inc., University of Texas at Houston |
| NCT00059605 | Phase 1 | Mar 1, 2003 | National Cancer Institute (NCI), University of Texas at Houston |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Texas at Houston | Academic/Hospital | 2 | 1 | 2 | 2003 |
| Genprex, Inc. | For profit | 1 | 1 | 1 | 2014 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2003 |
3 organizations
Page 1 / 1